It doesn't take a rocket scientist to see what's g
Post# of 154051
(Total Views: 686)
Posted On: 07/02/2021 7:56:14 AM
It doesn't take a rocket scientist to see what's going on here with the 5%. Their goal isn't to build Apollo 11. They want to either sell the intellectual property cheaply to the Russians before it ever gets to the launchpad, or they want to build another Challenger and see it implode before it ever reaches space so the remaining parts can be sold off. To the Russians.
It's Vulture Capital.
The constant shorting has only taken them so far. All the bullshit from AF and Culper Research has only been able to take them so far. Bringing horseshit lawsuits out en masse to scare investors has only been able to take them so far. It hasn't driven our price to $0 and it hasn't swayed NP and the board.
So what's left to do besides try to takeover and do it yourselves? And instead of putting together a business plan, or penning an elegant and powerful statement about their plans to reshape the future of the company, they release an inflammatory PR and create a site which basically reads like a slightly more professionally written law firm notice soliciting investors to chase ambulances with them.
It's just pathetic, to be honest.
When a single approval occurs or, perhaps even more importantly when NASH results meet the world, they're attempts to either gain control (to sell cheaply) or destroy CYDY to a point where it has to sell cheaply are over.
Gilead can't get Leronlimab on the cheap when it isn't cheap anymore.
I think it's extremely telling that the plan is to "unleash the potential value of Leronlimab" but not HOW to unleash the potential value of Leronlimab. They aren't saying "here are things that have occurred and here is how we would have handled them" but rather "look at all the scary things we're claiming your management team has been doing!"
It's big on vague business-speak like "challenge the status quo" or "usher in a new era" and completely devoid of any actual evidence of a plan or any valuable incite into how the valuable potential of our molecule could be unlocked. Straight from the basher playbook.
So what they're proposing is that five people with no current access to Cytodyn's massive amount of data, trials, discussions, and interactions with domestic and foreign regulatory bodies could step in and somehow immediately learn everything, adjust everything in some magical way, and bring us an approval faster than those who have been living and breathing it for the last 7 years?
Bullshit.
Here's the kicker. If they started this six months sooner, laid off the bashing techniques, presented an actual plan, and did it professionally, I think I may have been on board. I think a lot of people may have been on board.
But not this way.
And I think that alone tells us all we need to know.
- Respert
It's Vulture Capital.
The constant shorting has only taken them so far. All the bullshit from AF and Culper Research has only been able to take them so far. Bringing horseshit lawsuits out en masse to scare investors has only been able to take them so far. It hasn't driven our price to $0 and it hasn't swayed NP and the board.
So what's left to do besides try to takeover and do it yourselves? And instead of putting together a business plan, or penning an elegant and powerful statement about their plans to reshape the future of the company, they release an inflammatory PR and create a site which basically reads like a slightly more professionally written law firm notice soliciting investors to chase ambulances with them.
It's just pathetic, to be honest.
When a single approval occurs or, perhaps even more importantly when NASH results meet the world, they're attempts to either gain control (to sell cheaply) or destroy CYDY to a point where it has to sell cheaply are over.
Gilead can't get Leronlimab on the cheap when it isn't cheap anymore.
I think it's extremely telling that the plan is to "unleash the potential value of Leronlimab" but not HOW to unleash the potential value of Leronlimab. They aren't saying "here are things that have occurred and here is how we would have handled them" but rather "look at all the scary things we're claiming your management team has been doing!"
It's big on vague business-speak like "challenge the status quo" or "usher in a new era" and completely devoid of any actual evidence of a plan or any valuable incite into how the valuable potential of our molecule could be unlocked. Straight from the basher playbook.
So what they're proposing is that five people with no current access to Cytodyn's massive amount of data, trials, discussions, and interactions with domestic and foreign regulatory bodies could step in and somehow immediately learn everything, adjust everything in some magical way, and bring us an approval faster than those who have been living and breathing it for the last 7 years?
Bullshit.
Here's the kicker. If they started this six months sooner, laid off the bashing techniques, presented an actual plan, and did it professionally, I think I may have been on board. I think a lot of people may have been on board.
But not this way.
And I think that alone tells us all we need to know.
- Respert
(45)
(2)